New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA’s 5th Blood Pressure Drug Recall of 2019

Risk of contamination has led to several recalls this year, and could lead to blood pressure drug shortages.

Blood Pressure Exam / Image: Spencer Platt
Blood Pressure Exam / Image: Spencer Platt

No, this isn’t a repost; the FDA has issued its fifth blood pressure drug recall of the year due to fear of contamination. A recent NBC News article reported the latest recall of four lots of losartan, a prescription medicine used to treat high blood pressure and congestive heart failure, after they were found to contain a cancer-causing chemical. Legacy Pharmaceutical Packaging initiated the recall after a batch was found to contain trace amounts of NMBA, a nitrosamine that’s linked to bladder cancer. The FDA advises patients who take the drug to continue using them, but to discuss alternative treatments with their doctor or pharmacist immediately.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts